Ad is loading...
NFFFX
Price
$80.02
Change
-$0.79 (-0.98%)
Updated
Nov 15 closing price
RNWHX
Price
$79.27
Change
-$0.78 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

NFFFX vs RNWHX

Header iconNFFFX vs RNWHX Comparison
Open Charts NFFFX vs RNWHXBanner chart's image
American Funds New World F2
Price$80.02
Change-$0.79 (-0.98%)
VolumeN/A
CapitalizationN/A
American Funds New World R5E
Price$79.27
Change-$0.78 (-0.97%)
VolumeN/A
CapitalizationN/A
NFFFX vs RNWHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NFFFX vs. RNWHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NFFFX is a Buy and RNWHX is a Buy.

FUNDAMENTALS
Fundamentals
NFFFX (60.9B) and RNWHX (60.9B) have equal amount of cash in the bank . NFFFX (1.46) and RNWHX (1.44) have matching dividends . NFFFX was incepted earlier than RNWHX: NFFFX (16 years) vs RNWHX (9 years). NFFFX (32.00) and RNWHX (32.00) have comparable annual turnover. NFFFX (250) and RNWHX (250) have matching initial minimum investment requirements. NFFFX (11.48) and RNWHX (11.41) have marching annual gain over last year. NFFFX (16.90) and RNWHX (16.60) have equivalent 5 years return.
NFFFXRNWHXNFFFX / RNWHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years9 years-
Gain YTD7.0507.006101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRA250N/A-
Net Assets60.9B60.9B100%
Annual Yield % from dividends1.461.44102%
Returns for 1 year11.4811.41101%
Returns for 3 years-14.69-14.8399%
Returns for 5 years16.9016.60102%
Returns for 10 years40.39N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDCM11.610.61
+5.55%
Radcom Ltd
CBL27.26-0.03
-0.11%
CBL & Associates Properties
FLEX37.20-0.44
-1.17%
Flex Ltd
CPOP1.19-0.08
-6.30%
Pop Culture Group Co Ltd
DYN28.39-1.92
-6.33%
Dyne Therapeutics